BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31595366)

  • 1. Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer.
    Sekido Y; Nishimura J; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Haraguchi N; Hata T; Matsuda C; Mizushima T; Murata K; Hasegawa J; Mori M; Doki Y
    Surg Today; 2020 Mar; 50(3):292-297. PubMed ID: 31595366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
    Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of Extended Dissection of Lateral Pelvic Lymph Nodes During Laparoscopic Total Mesorectal Excision in Patients with Locally Advanced Lower Rectal Cancer: A Single-Center Pilot Study After Neoadjuvant Chemotherapy.
    Aisu Y; Kato S; Kadokawa Y; Yasukawa D; Kimura Y; Takamatsu Y; Kitano T; Hori T
    Med Sci Monit; 2018 Jun; 24():3966-3977. PubMed ID: 29890514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings.
    Kim MJ; Hur BY; Lee ES; Park B; Joo J; Kim MJ; Park SC; Baek JY; Chang HJ; Kim DY; Oh JH
    PLoS One; 2018; 13(4):e0195815. PubMed ID: 29649321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the Lymph Node Committee of Japanese Society for Cancer of the Colon and Rectum.
    Ogawa S; Hida J; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Sugihara K
    Int J Colorectal Dis; 2016 Oct; 31(10):1719-28. PubMed ID: 27576475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of lateral pelvic lymph node metastasis from lower rectal cancer using magnetic resonance imaging and risk factors for metastasis: Multicenter study of the Lymph Node Committee of the Japanese Society for Cancer of the Colon and Rectum.
    Ogawa S; Hida JI; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Okamoto T; Yamamoto M; Sugihara K; Watanabe T
    Int J Colorectal Dis; 2017 Oct; 32(10):1479-1487. PubMed ID: 28762189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Lateral Pelvic Lymph Node Metastasis in Advanced Low Rectal Cancer Treated With Neoadjuvant Chemotherapy.
    Ishizaki T; Katsumata K; Enomoto M; Mazaki J; Udo R; Tago T; Kasahara K; Kuwabara H; Nagakawa Y; Tsuchida A
    Anticancer Res; 2022 Apr; 42(4):2113-2121. PubMed ID: 35347035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results of simultaneous integrated boost intensity-modulated radiation therapy based neoadjuvant chemoradiotherapy on locally advanced rectal cancer with clinically suspected positive lateral pelvic lymph nodes.
    Geng JH; Zhang YZ; Li YH; Li S; Wang L; Wang ZL; Zhu XG; Bu ZD; Li ZY; Su XQ; Cai Y; Wu AW; Wang WH
    Ann Transl Med; 2021 Feb; 9(3):217. PubMed ID: 33708844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics Approach Outperforms Diameter Criteria for Predicting Pathological Lateral Lymph Node Metastasis After Neoadjuvant (Chemo)Radiotherapy in Advanced Low Rectal Cancer.
    Nakanishi R; Akiyoshi T; Toda S; Murakami Y; Taguchi S; Oba K; Hanaoka Y; Nagasaki T; Yamaguchi T; Konishi T; Matoba S; Ueno M; Fukunaga Y; Kuroyanagi H
    Ann Surg Oncol; 2020 Oct; 27(11):4273-4283. PubMed ID: 32767224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computed tomography texture analysis for the prediction of lateral pelvic lymph node metastasis of rectal cancer.
    Nakao T; Shimada M; Yoshikawa K; Tokunaga T; Nishi M; Kashihara H; Takasu C; Wada Y; Yoshimoto T
    World J Surg Oncol; 2022 Sep; 20(1):281. PubMed ID: 36057660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateral pelvic lymph node dissection can be omitted in lower rectal cancer in which the longest lateral pelvic and perirectal lymph node is less than 5 mm on MRI.
    Ogawa S; Itabashi M; Hirosawa T; Hashimoto T; Bamba Y; Kameoka S
    J Surg Oncol; 2014 Mar; 109(3):227-33. PubMed ID: 24165955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.
    Yamamoto T; Kawada K; Hida K; Ganeko R; Inamoto S; Yoshitomi M; Watanabe T; Sakai Y
    Int J Clin Oncol; 2019 Jun; 24(6):677-685. PubMed ID: 30721379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer After Total Neoadjuvant Therapy (TNT).
    Peacock O; Manisundaram N; Dibrito SR; Kim Y; Hu CY; Bednarski BK; Konishi T; Stanietzky N; Vikram R; Kaur H; Taggart MW; Dasari A; Holliday EB; You YN; Chang GJ
    Ann Surg; 2022 Oct; 276(4):654-664. PubMed ID: 35837891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
    Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically enlarged lateral pelvic lymph nodes do not influence prognosis after neoadjuvant therapy and TME in stage III rectal cancer.
    Dharmarajan S; Shuai D; Fajardo AD; Birnbaum EH; Hunt SR; Mutch MG; Fleshman JW; Lin AY
    J Gastrointest Surg; 2011 Aug; 15(8):1368-74. PubMed ID: 21533959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer.
    Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Baba H
    Int J Clin Oncol; 2020 Jan; 25(1):110-117. PubMed ID: 31407167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of Lymph Node-Positive Cases Based on Perirectal and Lateral Pelvic Lymph Nodes Using Magnetic Resonance Imaging: Study of the Japanese Society for Cancer of the Colon and Rectum.
    Ogawa S; Hida J; Ike H; Kinugasa T; Ota M; Shinto E; Itabashi M; Kameoka S; Sugihara K
    Ann Surg Oncol; 2016 Apr; 23(4):1187-94. PubMed ID: 26671038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateral Pelvic Lymph Node Metastases in Rectal Cancer: A Systematic Review.
    Atef Y; Koedam TW; van Oostendorp SE; Bonjer HJ; Wijsmuller AR; Tuynman JB
    World J Surg; 2019 Dec; 43(12):3198-3206. PubMed ID: 31468119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is neoadjuvant chemoradiotherapy sufficient in patients with advanced rectal malignancy and positive extra-mesorectal lateral lymph nodes?
    Ahmadi N; Brown KGM; Lee P; Quinn M; Austin KKS; Solomon MJ
    Colorectal Dis; 2020 Jun; 22(6):689-693. PubMed ID: 31909851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of indocyanine green-enhanced near-infrared fluorescence-guided imaging in laparoscopic lateral pelvic lymph node dissection for middle-low rectal cancer.
    Zhou SC; Tian YT; Wang XW; Zhao CD; Ma S; Jiang J; Li EN; Zhou HT; Liu Q; Liang JW; Zhou ZX; Wang XS
    World J Gastroenterol; 2019 Aug; 25(31):4502-4511. PubMed ID: 31496628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.